Neurotrope (NTRP) EV/EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -1.82 | -0.91 | -0.16 | -2.30 | -2.25 | |||
| Changes by years, y/y, % | -88% | -50% | -83% | -100% | +6.0% | ||||
Neurotrope. EV/EBITDA
Neurotrope. EV/EBITDA, changes, %
Neurotrope (NTRP) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q3 | 2025Q4 | 2026Q1 | 2026Q2 | 2026Q3 | LTM ? | |||
| EV/EBITDA | ? | -0.43 | -0.91 | -0.25 | -0.17 | -0.15 | -2.25 | |
| Changes by years, y/y, % | -72% | +36% | -65% | |||||
| Changes by quarters, q/q, % | -36% | +112% | -73% | -33% | -9% | |||